首页> 外文OA文献 >Immunochemistry and Lung Cancer: Application in Diagnosis, Prognosis and Targeted Therapy
【2h】

Immunochemistry and Lung Cancer: Application in Diagnosis, Prognosis and Targeted Therapy

机译:免疫化和肺癌:在诊断,预后和靶向治疗中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Immunochemistry is now an established ancillary technique in lung cancer diagnosis. Not only does it help in supporting the morphological diagnosis of malignancy, but its role now extends to the determination of cell lineage, ascertaining the primary site of tumour origin and contributing to decisions on prognosis and treatment. Early detection and confirmation of lung cancer facilitate early treatment decisions. Lung cancer management now has a multidisciplinary approach which includes cytopathologists and clinicians. Some clinicians may not understand what immunochemistry is and what its role is in lung cancer diagnosis, prognosis and therapy. The purpose of this paper is to define immunochemistry, on the background of basic respiratory airway epithelial structure and cancer biology, and discuss its application in the diagnosis, treatment and determination of prognosis of lung cancer. © 2011 S. Karger AG, Basel.
机译:ImmunoPemisty现在是肺癌诊断中的辅助技术。它不仅有助于支持恶性肿瘤的形态学诊断,但其作用现在延伸到细胞谱系的测定,确定肿瘤起源的主要部位并有助于关于预后和治疗的决定。肺癌的早期检测和确认促进了早期治疗决策。肺癌管理现在具有多学科方法,包括细胞病变和临床医生。一些临床医生可能不了解什么免疫化学以及其作用在肺癌诊断,预后和治疗中的作用。本文的目的是在基本呼吸道气道上皮结构和癌症生物学的背景下定义免疫化学,并探讨其在肺癌预后的诊断,治疗和测定中的应用。 ©2011 S. Karger AG,巴塞尔。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号